ACRP members have exclusive access to free webinars and training courses (without contact hours) and receive deeply discounted rates when earning ACRP Contact Hours. Learn more >
Good Clinical Practice (GCP) ICH E6(R3)
GCP/ICH Related Courses
ACRP will update many of its training courses to reflect the ICH E6(R3) guidelines.
Content to help clinical research professionals stay ahead in this rapidly evolving industry.
ICH E6(R3) Preparation Documents
Webinar and Conference Replays
ACRP Insights
Relevant resources from Authorities and Organizations support the education of all researchers.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
U.S. Food & Drug Administration (FDA) Guidance Documents
The International Organization for Standardization (ISO)
The U.S. Department of Health & Human Services (HHS)
World Medical Association (WMA)


How do I know which guidance pertains to my role?
Every role is different and can depend on the type of trials and indications you are working on. ACRP has created a list of the most common guidance referenced within our resources and utilized on our certification exams. This is not an exhaustive list but rather a list of some of the common guidance.
Do the links direct me to a particular guidance document?
There are a few links that direct you directly to the guidance (ISO and WMA), the rest will direct you to resource pages that may need to be searched for the guidance you are looking for.
Does ACRP have any additional resources to learn more about clinical research regulations and guidance?
At the top of the Guidance and Regulations Resource Center, you will find ACRP resources related to guidance within the industry. These resources may share best practices in implementing these guidelines as well as resources for learning and testing your know knowledge of the guidance.
When will the ACRP Certification Exams reflect the ICH Guideline changes?
ACRP will incorporate the updated ICH Guideline for Good Clinical Practice E6(R3) into all ACRP Certification examinations within the next two years, based on its final adoption date of January 6, 2025. This ensures that candidates have sufficient time to accumulate the required 3,000 hours of professional experience under the revised guideline. Please read additional details in this announcement (dated February 25, 2025).
What are the changes expected for ICH E6(R3)?
The International Council for Harmonisation (ICH) released its long-awaited and final guidance to update ICH E6(R2) in January 2025. The follows the first draft release which was disseminated in 2023. The new guidance is ICH E6(R3). This standard helps to assure that the rights, safety, and well-being of trial participants are protected, that the conduct is consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial results are reliable.
How will this pending change from the ICH E6 impact my role—or the roles of my team?
The changes in the ICH E6 guideline impact all those whose roles involve conducting and leading clinical research. It is critical to understand the specific guidance changes and their impact on the day-to-day implementation of clinical trials and studies—and how to incorporate the changes into trial implementation.
When should we be expected to put these changes into action?
Upon release of the new guidance, every organization—whether sponsor, CRO, or site—should immediately take action to review the new guidance and understand the changes. ACRP will release a series of resources that will help you understand and communicate the changes to your team and into your organization.
How do I train my teams on the new guidance?
ACRP is responding rapidly to adapt all its educational and training materials to ensure the new guidance is incorporated. Our first priority will be to relaunch our Introduction to Good Clinical Practice course and adapt all ACRP Foundational Training. We will also ensure all ACRP Continuing Education is updated, an effort we expect to continue through 2025.